Value Ebitda vs Research Development Analysis

VALU Stock

USD 51.32 0.37 0.73%

Value Line financial indicator trend analysis is much more than just breaking down Value Line prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Value Line is a good investment. Please check the relationship between Value Line Ebitda and its Research Development accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Value Line. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Value Stock please use our How to Invest in Value Line guide.

Ebitda vs Research Development

Ebitda vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Value Line Ebitda account and Research Development. At this time, the significance of the direction appears to have pay attention.

The correlation between Value Line's Ebitda and Research Development is -0.76. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Research Development in the same time period over historical financial statements of Value Line, assuming nothing else is changed. The correlation between historical values of Value Line's Ebitda and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Value Line are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Ebitda i.e., Value Line's Ebitda and Research Development go up and down completely randomly.

Correlation Coefficient

-0.76

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ebitda

Research Development

Most indicators from Value Line's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Value Line current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Value Line. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Value Stock please use our How to Invest in Value Line guide.At this time, Value Line's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 34.01 in 2024, whereas Selling General Administrative is likely to drop slightly above 4.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	23.2M	24.5M	32.0M	44.0M
Total Revenue	40.5M	39.7M	37.5M	51.7M

Gross Profit Total Revenue

Value Line fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Good Will	Other Liab	Other Assets
Total Assets		-0.86	0.28	0.23	0.98	0.6	-0.12	0.97	0.42	0.31	-0.47	0.98	0.08	-0.51	-0.22	0.62	-0.93	-0.11	0.77	0.99	-0.55	-0.7	-0.27	-0.56	-0.07	-0.75
Short Long Term Debt Total	-0.86		-0.29	0.08	-0.9	-0.3	0.06	-0.92	-0.25	-0.06	0.17	-0.89	0.1	0.37	0.14	-0.65	0.86	0.38	-0.6	-0.88	0.44	0.6	0.06	0.45	-0.02	0.52
Other Current Liab	0.28	-0.29		-0.24	0.32	0.1	0.42	0.24	-0.18	0.05	0.3	0.3	0.25	-0.75	0.33	0.11	-0.43	-0.29	0.14	0.28	-0.48	-0.23	0.31	-0.48	0.43	-0.25
Total Current Liabilities	0.23	0.08	-0.24		0.17	0.13	-0.37	0.12	0.11	0.33	-0.85	0.22	-0.49	-0.29	-0.72	0.26	-0.29	0.3	0.06	0.18	0.26	-0.44	-0.93	0.27	-0.67	-0.52
Total Stockholder Equity	0.98	-0.9	0.32	0.17		0.48	-0.12	0.99	0.39	0.16	-0.44	1.0	0.02	-0.52	-0.28	0.61	-0.95	-0.28	0.69	1.0	-0.62	-0.72	-0.23	-0.63	-0.03	-0.78
Property Plant And Equipment Net	0.6	-0.3	0.1	0.13	0.48		0.07	0.47	0.43	0.76	-0.22	0.46	0.62	-0.16	0.29	0.22	-0.36	0.59	0.9	0.5	-0.22	-0.11	-0.01	-0.23	-0.05	-0.21
Net Debt	-0.12	0.06	0.42	-0.37	-0.12	0.07		-0.13	-0.8	-0.04	0.48	-0.13	0.49	-0.13	0.47	0.06	0.04	0.02	0.15	-0.11	-0.18	0.28	0.46	-0.18	0.2	0.22
Retained Earnings	0.97	-0.92	0.24	0.12	0.99	0.47	-0.13		0.4	0.12	-0.43	0.98	0.03	-0.41	-0.27	0.57	-0.92	-0.28	0.71	0.99	-0.6	-0.7	-0.22	-0.61	-0.02	-0.74
Cash	0.42	-0.25	-0.18	0.11	0.39	0.43	-0.8	0.4		0.28	-0.33	0.38	0.06	0.03	-0.09	-0.02	-0.21	0.12	0.31	0.4	-0.21	-0.26	-0.13	-0.2	0.07	-0.28
Non Current Assets Total	0.31	-0.06	0.05	0.33	0.16	0.76	-0.04	0.12	0.28		-0.11	0.14	0.28	-0.21	0.3	0.25	-0.14	0.79	0.59	0.16	0.34	0.05	-0.13	0.34	-0.22	0.07
Non Currrent Assets Other	-0.47	0.17	0.3	-0.85	-0.44	-0.22	0.48	-0.43	-0.33	-0.11		-0.48	0.38	0.14	0.84	-0.15	0.46	-0.07	-0.25	-0.46	0.06	0.63	0.91	0.05	0.55	0.74
Cash And Short Term Investments	0.98	-0.89	0.3	0.22	1.0	0.46	-0.13	0.98	0.38	0.14	-0.48		-0.03	-0.53	-0.32	0.63	-0.96	-0.27	0.67	1.0	-0.61	-0.76	-0.29	-0.61	-0.06	-0.81
Net Receivables	0.08	0.1	0.25	-0.49	0.02	0.62	0.49	0.03	0.06	0.28	0.38	-0.03		0.12	0.7	-0.29	0.13	0.35	0.49	0.04	-0.4	0.36	0.61	-0.4	0.47	0.19
Common Stock Shares Outstanding	-0.51	0.37	-0.75	-0.29	-0.52	-0.16	-0.13	-0.41	0.03	-0.21	0.14	-0.53	0.12		0.08	-0.55	0.69	0.2	-0.19	-0.49	0.4	0.5	0.13	0.4	-0.06	0.53
Non Current Liabilities Total	-0.22	0.14	0.33	-0.72	-0.28	0.29	0.47	-0.27	-0.09	0.3	0.84	-0.32	0.7	0.08		-0.16	0.34	0.34	0.18	-0.28	0.0	0.53	0.85	-0.01	0.56	0.64
Other Current Assets	0.62	-0.65	0.11	0.26	0.61	0.22	0.06	0.57	-0.02	0.25	-0.15	0.63	-0.29	-0.55	-0.16		-0.67	-0.1	0.36	0.6	-0.14	-0.4	-0.18	-0.15	-0.32	-0.34
Other Stockholder Equity	-0.93	0.86	-0.43	-0.29	-0.95	-0.36	0.04	-0.92	-0.21	-0.14	0.46	-0.96	0.13	0.69	0.34	-0.67		0.3	-0.6	-0.94	0.55	0.78	0.34	0.55	0.07	0.81
Total Liab	-0.11	0.38	-0.29	0.3	-0.28	0.59	0.02	-0.28	0.12	0.79	-0.07	-0.27	0.35	0.2	0.34	-0.1	0.3		0.35	-0.24	0.5	0.27	-0.14	0.5	-0.21	0.3
Property Plant And Equipment Gross	0.77	-0.6	0.14	0.06	0.69	0.9	0.15	0.71	0.31	0.59	-0.25	0.67	0.49	-0.19	0.18	0.36	-0.6	0.35		0.71	-0.31	-0.28	-0.03	-0.32	-0.05	-0.33
Total Current Assets	0.99	-0.88	0.28	0.18	1.0	0.5	-0.11	0.99	0.4	0.16	-0.46	1.0	0.04	-0.49	-0.28	0.6	-0.94	-0.24	0.71		-0.63	-0.74	-0.26	-0.63	-0.03	-0.79
Intangible Assets	-0.55	0.44	-0.48	0.26	-0.62	-0.22	-0.18	-0.6	-0.21	0.34	0.06	-0.61	-0.4	0.4	0.0	-0.14	0.55	0.5	-0.31	-0.63		0.41	-0.23	1.0	-0.42	0.6
Accounts Payable	-0.7	0.6	-0.23	-0.44	-0.72	-0.11	0.28	-0.7	-0.26	0.05	0.63	-0.76	0.36	0.5	0.53	-0.4	0.78	0.27	-0.28	-0.74	0.41		0.58	0.41	0.08	0.87
Short Term Debt	-0.27	0.06	0.31	-0.93	-0.23	-0.01	0.46	-0.22	-0.13	-0.13	0.91	-0.29	0.61	0.13	0.85	-0.18	0.34	-0.14	-0.03	-0.26	-0.23	0.58		-0.24	0.64	0.6
Good Will	-0.56	0.45	-0.48	0.27	-0.63	-0.23	-0.18	-0.61	-0.2	0.34	0.05	-0.61	-0.4	0.4	-0.01	-0.15	0.55	0.5	-0.32	-0.63	1.0	0.41	-0.24		-0.42	0.6
Other Liab	-0.07	-0.02	0.43	-0.67	-0.03	-0.05	0.2	-0.02	0.07	-0.22	0.55	-0.06	0.47	-0.06	0.56	-0.32	0.07	-0.21	-0.05	-0.03	-0.42	0.08	0.64	-0.42		0.15
Other Assets	-0.75	0.52	-0.25	-0.52	-0.78	-0.21	0.22	-0.74	-0.28	0.07	0.74	-0.81	0.19	0.53	0.64	-0.34	0.81	0.3	-0.33	-0.79	0.6	0.87	0.6	0.6	0.15

Click cells to compare fundamentals

Value Line Account Relationship Matchups

Value Line fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	109.7M	121.1M	128.7M	131.1M	136.0M	118.4M
Other Current Liab	4.8M	1.6M	3.4M	3.9M	4.3M	8.1M
Total Current Liabilities	26.8M	27.9M	23.8M	23.3M	22.3M	30.0M
Total Stockholder Equity	53.5M	67.0M	79.6M	83.7M	90.8M	70.0M
Property Plant And Equipment Net	9.5M	8.3M	7.1M	5.8M	4.4M	4.7M
Net Debt	6.8M	(8.4M)	(22.3M)	(1.5M)	394K	413.7K
Retained Earnings	56.5M	72.5M	87.6M	96.0M	104.2M	64.0M
Cash	5.0M	19.2M	29.7M	7.6M	4.4M	4.2M
Non Current Assets Total	69.2M	69.9M	67.4M	65M	65.0M	68.4M
Non Currrent Assets Other	(12.4M)	(12.4M)	(12.8M)	(12.8M)	305K	289.8K
Cash And Short Term Investments	34.2M	45.4M	57.8M	62.1M	68.3M	50.0M
Net Receivables	5.0M	4.0M	1.7M	2.1M	1.3M	1.2M
Common Stock Shares Outstanding	9.6M	9.6M	9.5M	9.5M	9.4M	7.9M
Liabilities And Stockholders Equity	109.7M	121.1M	128.7M	131.1M	136.0M	118.4M
Non Current Liabilities Total	29.4M	26.2M	25.3M	24.1M	23.0M	26.5M
Other Current Assets	1.3M	1.9M	1.8M	1.9M	2.5M	2.4M
Other Stockholder Equity	(5.0M)	(6.5M)	(9.0M)	(13.7M)	(14.2M)	(13.5M)
Total Liab	56.2M	54.1M	49.1M	47.4M	45.2M	48.3M
Property Plant And Equipment Gross	9.5M	8.3M	7.1M	10.4M	7.0M	4.9M
Total Current Assets	40.5M	51.2M	61.3M	66.1M	71.0M	49.9M
Accumulated Other Comprehensive Income	1.1M	3K	(24K)	374K	(253K)	(240.4K)
Intangible Assets	69K	143K	71K	132K	151.8K	144.2K
Accounts Payable	2.1M	2.1M	1.3M	1.3M	1.4M	1.4M
Other Liab	18.9M	18.7M	18.8M	19.2M	17.3M	20.0M
Short Term Investments	29.2M	26.2M	28.1M	54.5M	64.0M	67.2M
Inventory	254K	1.0	616K	(1.2M)	(1.0M)	(991.8K)
Treasury Stock	(4.7M)	(6.0M)	(7.5M)	(10.0M)	(9.0M)	(8.5M)
Property Plant Equipment	9.5M	8.3M	7.1M	5.8M	5.2M	4.3M
Current Deferred Revenue	18.9M	19.2M	17.7M	16.8M	15.8M	18.2M
Net Tangible Assets	53.5M	66.9M	79.6M	83.5M	96.1M	50.3M
Retained Earnings Total Equity	56.5M	72.5M	87.6M	96.0M	110.4M	56.1M
Deferred Long Term Liab	5.8M	18.9M	18.7M	19.3M	17.4M	15.6M
Long Term Investments	59.2M	61.0M	60.0M	58.8M	60.1M	64.5M
Net Invested Capital	55.9M	69.3M	79.6M	83.7M	90.8M	69.9M
Net Working Capital	13.7M	23.3M	37.6M	42.8M	48.8M	51.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Value Stock Analysis

When running Value Line's price analysis, check to measure Value Line's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Value Line is operating at the current time. Most of Value Line's value examination focuses on studying past and present price action to predict the probability of Value Line's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Value Line's price. Additionally, you may evaluate how the addition of Value Line to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC